David Ian Rabuka is listed as an executive officer, director, and promoter on 8 SEC Form D filings by 3 issuers between Mar 2010 and Apr 2022: REDWOOD BIOSCIENCE INC (Emeryville, CA — biotechnology — 2010–2014; $8.65M reported sold to 11 investors), DNAlite Therapeutics, Inc. (San Francisco, CA — biotechnology — 2022; $5.6M reported sold to 18 investors) and ACRIGEN BIOSCIENCES, INC. (Kensington, CA — biotechnology — 2019; $775K reported sold to 9 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer, director, and promoter, over about 12 years. Across those companies the filings report $15M sold in total.
Listed alongside Karen Boezi (7 shared filings), Michael Blank (6 shared filings), Carolyn Bertozzi (4 shared filings), Paul Socolow (4 shared filings), BARRY LITTLEJOHNS (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for David Ian Rabuka and found 13 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.